138 related articles for article (PubMed ID: 37767815)
21. Predictors of overall survival in human papillomavirus-associated oropharyngeal cancer using the National Cancer Data Base.
Amini A; Jasem J; Jones BL; Robin TP; McDermott JD; Bhatia S; Raben D; Jimeno A; Bowles DW; Karam SD
Oral Oncol; 2016 May; 56():1-7. PubMed ID: 27086480
[TBL] [Abstract][Full Text] [Related]
22. Human Papillomavirus-Negative Oropharyngeal Cancer Survival Outcomes Based on Primary Treatment: National Cancer Database Analysis.
Shama M; Al-Qurayshi Z; Dahl M; Amdur RJ; Bates J; Mendenhall W; Hitchcock K; Festa BM; Ghanem T; Dziegielewski PT
Otolaryngol Head Neck Surg; 2022 Jul; 167(1):100-108. PubMed ID: 34546828
[TBL] [Abstract][Full Text] [Related]
23. A prospective evaluation of neck and shoulder function following treatments of early-stage human papillomavirus-associated oropharynx cancer.
Gulati A; Plonowska-Hirschfeld K; Stephens EM; Kansara S; Zebolsky AL; Ochoa E; Xu MJ; Ha PK; Heaton CM; Yom SS; Chan JW; Algazi AP; Kang H; Ryan WR
Clin Otolaryngol; 2023 Sep; 48(5):756-765. PubMed ID: 37212448
[TBL] [Abstract][Full Text] [Related]
24. Neck scar perception after neck dissection in HPV-associated oropharyngeal squamous cell carcinoma.
Au VH; Miller LE; Mitchell MB; Larson AR; Lin DT; Feng AL; Richmon JD
Am J Otolaryngol; 2024; 45(1):104074. PubMed ID: 37865986
[TBL] [Abstract][Full Text] [Related]
25. Mature results of a prospective study of deintensified chemoradiotherapy for low-risk human papillomavirus-associated oropharyngeal squamous cell carcinoma.
Chera BS; Amdur RJ; Tepper JE; Tan X; Weiss J; Grilley-Olson JE; Hayes DN; Zanation A; Hackman TG; Patel S; Sheets N; Weissler MC; Mendenhall WM
Cancer; 2018 Jun; 124(11):2347-2354. PubMed ID: 29579339
[TBL] [Abstract][Full Text] [Related]
26. Extranodal extension is a strong prognosticator in HPV-positive oropharyngeal squamous cell carcinoma.
Bauer E; Mazul A; Chernock R; Rich J; Jackson RS; Paniello R; Pipkorn P; Oppelt P; Gay H; Daly M; El-Mofty S; Thorstad W; Adkins D; Zevallos J
Laryngoscope; 2020 Apr; 130(4):939-945. PubMed ID: 31077394
[TBL] [Abstract][Full Text] [Related]
27. Changing prognostic significance of tumor stage and nodal stage in patients with squamous cell carcinoma of the oropharynx in the human papillomavirus era.
Keane FK; Chen YH; Neville BA; Tishler RB; Schoenfeld JD; Catalano PJ; Margalit DN
Cancer; 2015 Aug; 121(15):2594-602. PubMed ID: 25873094
[TBL] [Abstract][Full Text] [Related]
28. Outcomes of definitive local therapy with intensity-modulated radiation therapy in elderly patients ≥70 years with HPV-associated oropharyngeal cancer.
Baliga S; Yildiz V; Barve R; Farag A; Bhateja P; Gogineni E; Mitchell D; Konieczkowski D; Grecula J; Ma SJ; Zhu S; Liu X; Bonomi M; Blakaj DM
J Med Virol; 2023 Dec; 95(12):e29293. PubMed ID: 38054393
[TBL] [Abstract][Full Text] [Related]
29. Radiotherapy versus Surgery in Early-Stage HPV-Positive Oropharyngeal Cancer.
Kim DY; Wu HG; Kim JH; Lee JH; Ahn SH; Chung EJ; Eom KY; Jung YH; Jeong WJ; Kwon TK; Kim S; Wee CW
Cancer Res Treat; 2022 Apr; 54(2):406-416. PubMed ID: 34176249
[TBL] [Abstract][Full Text] [Related]
30. Predictors of Mortality in HPV-Associated Oropharynx Carcinoma Treated With Surgery Alone.
Han M; Stanford-Moore GB; Larson AR; Schoppy DW; Cognetti DM; Joshi AS; Houlton JJ; Ryan WR
Laryngoscope; 2020 Jul; 130(7):E423-E435. PubMed ID: 31675132
[TBL] [Abstract][Full Text] [Related]
31. The role of concomitant chemoradiotherapy versus radiation alone in T1-3N0 HPV-positive and HPV-negative oropharyngeal squamous cell carcinoma.
Shiao JC; Holt D; Ladbury C; Gao D; Jones B; Karam SD; Amini A
Oral Oncol; 2022 Jul; 130():105907. PubMed ID: 35605559
[TBL] [Abstract][Full Text] [Related]
32. Etiology, diagnosis, treatment, and prevention of human papilloma virus-associated oropharyngeal squamous cell carcinoma.
Shinomiya H; Nibu KI
Int J Clin Oncol; 2023 Aug; 28(8):975-981. PubMed ID: 37093464
[TBL] [Abstract][Full Text] [Related]
33. Outcomes following TORS for HPV-positive oropharyngeal carcinoma: PEGs, tracheostomies, and beyond.
Van Abel KM; Quick MH; Graner DE; Lohse CM; Price DL; Price KAR; Ma DJ; Moore EJ
Am J Otolaryngol; 2019; 40(5):729-734. PubMed ID: 31303455
[TBL] [Abstract][Full Text] [Related]
34. Impact of Lymph Node Yield on Survival in Surgically Treated Oropharyngeal Squamous Cell Carcinoma.
Gomez ED; Chang JC; Ceremsak JJ; Brody RM; Brant JA; Rassekh CH; Weinstein GS; Newman JG
Otolaryngol Head Neck Surg; 2021 Jan; 164(1):146-156. PubMed ID: 32689888
[TBL] [Abstract][Full Text] [Related]
35. The Incidence, Survival, and HPV Impact of Second Primary Cancer following Primary Oropharyngeal Squamous Cell Carcinoma: A 20-Year Retrospective and Population-Based Study.
Andersen L; Jakobsen KK; Carlander AF; Garset-Zamani M; Friborg J; Kiss K; Marvig RL; Olsen C; Nielsen FC; Andersen E; Grønhøj C; Buchwald CV
Viruses; 2022 Dec; 15(1):. PubMed ID: 36680074
[TBL] [Abstract][Full Text] [Related]
36. PET/CT Poorly Predicts AJCC 8th Edition Pathologic Staging in HPV-Related Oropharyngeal Cancer.
Snyder V; Goyal LK; Bowers EMR; Kubik M; Kim S; Ferris RL; Johnson JT; Duvvuri U; Gooding WE; Branstetter BF; Rath TJ; Sridharan SS
Laryngoscope; 2021 Jul; 131(7):1535-1541. PubMed ID: 33428218
[TBL] [Abstract][Full Text] [Related]
37. Sex-specific aspects in patients with oropharyngeal squamous cell carcinoma: a bicentric cohort study.
Klasen C; Wuerdemann N; Rothbart P; Prinz J; Eckel HNC; Suchan M; Kopp C; Johannsen J; Ziogas M; Charpentier A; Huebbers CU; Sharma SJ; Langer C; Arens C; Wagner S; Quaas A; Klußmann JP
BMC Cancer; 2023 Nov; 23(1):1054. PubMed ID: 37919644
[TBL] [Abstract][Full Text] [Related]
38. Quality of Life and Depression Symptoms After Therapy De-Escalation in HPV+ Oropharyngeal Squamous Cell Carcinoma: A Nonrandomized Controlled Trial.
Panwar A; Shah S; Reid AE; Lydiatt W; Holcomb AJ; Osmolak A; Coughlin A; Militsakh O; Su YB; Mirmiran A; Huang TS; Nolan N; Duckert R; Barney C; Chiu M; Nguyen C; Sayles H; Ganti AK; Lindau R
JAMA Otolaryngol Head Neck Surg; 2024 May; 150(5):429-435. PubMed ID: 38573597
[TBL] [Abstract][Full Text] [Related]
39. Risk of Pathologic Extranodal Extension and Other Adverse Features After Transoral Robotic Surgery in Patients With HPV-Positive Oropharynx Cancer.
Zebolsky AL; George E; Gulati A; Wai KC; Carpenter P; Van Zante A; Ha PK; Heaton CM; Ryan WR
JAMA Otolaryngol Head Neck Surg; 2021 Dec; 147(12):1080-1088. PubMed ID: 34673904
[TBL] [Abstract][Full Text] [Related]
40. Prognostic Significance of Smoking in Human Papillomavirus-Positive Oropharyngeal Cancer Under American Joint Committee on Cancer Eighth Edition Stage.
Chidambaram S; Nakken ER; Kennedy W; Thorstad WL; Chen SY; Pipkorn P; Zevallos JP; Mazul AL
Laryngoscope; 2020 Aug; 130(8):1961-1966. PubMed ID: 32293733
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]